Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Combined Preeclampsia Test Superior to U.K. Standards

Combined Preeclampsia Test Superior to U.K. Standards

A “preeclampsia screening” metric combining statistical methods plus certain biomarkers improved detection of preeclampsia compared with the standard of care in the United Kingdom, researchers found.

Combining certain maternal risk factors with biomarkers, such as mean arterial pressure, uterine artery pulsatility index, serum placental growth factor, and serum pregnancy-associated plasma protein-A, to be able to detect preeclampsia at any point during pregnancy better than current National Institute for Health and Care Excellence (NICE) guidelines in the U.K., reported M.Y. Tan, MD, of King’s College Hospital in London, and colleagues.

Writing in Ultrasound in Obstetrics and Gynecology, the authors said that an improved metric could potentially help to identify which women at risk of preeclampsia would most benefit from prophylactic use of aspirin.

But the researchers pointed out the weaknesses of the current NICE guidelines, which consider women at “high risk” of developing preeclampsia if they have one “major” factor (history of hypertensive disease in previous pregnancy, chronic kidney disease, autoimmune disease, diabetes mellitus, or chronic hypertension) or two “moderate” factors (first pregnancy at age 40 or over, an interpregnancy interval of more than 10 years, bond-mass index of over 35, or family history of preeclampsia).

The team therefore proposed an alternative: a Bayes’ theorem-based method that combined maternal risk factors with certain biomarkers. To test this hypothesis, the researchers performed a prospective multicenter cohort study in seven National Health Service (NHS) maternity hospitals in England.

Participants were women who were older than age 18 with a singleton pregnancy and a live fetus at the 11-13 week ultrasound. The women were tested using the NICE method compared with the “mini-combined test,” using the Bayes’ theorem-based method to combine maternal factors, mean arterial pressure, and serum pregnancy-associated protein-A.

Overall, data was available on a total of 16,747 participants. Of these, preeclampsia developed in 473 pregnancies, 142 of which had preterm preeclampsia.

The screen-positive rates for the NICE method were 10.3%, the authors said, while the detection rate for all preeclampsia was 30.4% (95% CI 26.3-34.6%). However, using the Bayes’ theorem-based method, the detection rate of all preeclampsia was 42.5%, (95% CI 38.0-46.8%).

A total of 256 patients took aspirin who were screen-positive by the NICE method and the mini-combined test, 144 patients who were screen-positive by the NICE method and screen negative by the mini-combined test, and 48 patients who were screen-negative for both tests.

After the researchers adjusted for the effect of aspirin, the detection rate of the NICE method was 31.5% (95% CI 27.3-35.7%) and the Bayes’ theorem-based method was 42.8% (95% CI 38.3-47.2%).

Secondary outcomes found similar results when comparing the two methods for detecting preterm preeclampsia, with screen-positive rates of 28.2% with the NICE method compared with 69.0% for the Bayes’ theorem mini-test. When the uterine pulsatility index, another biomarker, was added, the detection rate increased to 82.4%.

The authors noted that the combined test is available on the Fetal Medicine Foundation site as a risk calculator and an app.

One of the co-authors, Liona Poon, MD, also of King’s College, said in a statement that the results “provide definitive proof to support risk-based screening for preterm pre-eclampsia using various biomarkers. It is now time to revise the professional guidelines and to move away from using a checklist-based method for screening.”

This study was supported by grants from the U.K. government.

Reagents and equipment for the measurement of serum placental growth factor were provided free of charge by PerkinElmer Life and Analytical Sciences and Thermo Fisher Scientific.

2018-03-15T15:16:12-0400

Tagged with:

About author

Related Articles